Influence of Social and Cultural Factors on the Decision to Consent for Monoclonal Antibody Treatment among High-Risk Patients with Mild-Moderate COVID-19

BACKGROUND: The clinical outcomes of patients who decline anti-spike monoclonal antibody therapies for coronavirus disease-2019 (COVID-19) is not known. Factors associated with the decision to accept or decline the offer for anti-spike monoclonal antibody therapies are not established. This study ai...

Descripción completa

Detalles Bibliográficos
Autores principales: Bierle, Dennis M., Ganesh, Ravindra, Wilker, Caroline G., Hanson, Sara N., Moehnke, Darcie E., Jackson, Tammy A., Ramar, Priya, Rosedahl, Jordan K., Philpot, Lindsey M., Razonable, Raymund R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8155772/
https://www.ncbi.nlm.nih.gov/pubmed/34032171
http://dx.doi.org/10.1177/21501327211019282

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8155772/
https://www.ncbi.nlm.nih.gov/pubmed/34032171
http://dx.doi.org/10.1177/21501327211019282

Ejemplares similares